Tagged with manufactu

China Dr Shun Luo, chairman, founder and CEO of Thousand Oaks Biopharmaceuticals, shares the company’s vision to deliver more accessible and affordable biologics to patients globally by lowering the cost of goods manufactured (COGM) per gram of recombinant protein; the paradigm-shifting technology and processes Thousand Oaks Biopharmaceuticals is innovating as an…

Puerto Rico GK CMO, a Puerto Rican contract manufacturing organization (CMO) recently inaugurated its manufacturing facility on the island. With the potential to manufacture advanced biologic and biosimilar products, the event could herald the beginning of a new era for Puerto Rican pharma manufacturing and was thus attended by two of the…

Egypt Dr Hany Mashaal, general manager for Egypt and the Rest of Middle East for Sun Pharma, explains the importance of Egypt for the Indian company, having recently opened a manufacturing facility in the country. He highlights the need for a faster drug registration process and gives an outlook at the…

Puerto Rico Ivan Lugo, executive director at Puerto Rico’s Industry University Research Center, Inc. (INDUNIV) with over 40 years of global pharmaceutical expertise, explains how his not-for-profit organization promotes Puerto Rico’s competitiveness in science and technology by facilitating collaboration between industry, government and academia. He also highlights how the island aims to…

Puerto Rico With more than 50 years of experience in pharmaceutical manufacturing, Puerto Rico is today a manufacturing base for 11 of the world’s 20 largest pharmaceutical and biopharmaceutical companies. However, considering its economic struggles and rising competition both from US states and international manufacturing hubs such as Ireland and Singapore, the…

Spain Jesús Donado, CEO of B. Braun Spain introduces the company’s strong footprint in Spain, as a manufacturing hub and a global centre of excellence for the company. Donado also discusses the challenge of offering solution and treatment-based services, while having to sell through product and volume-based tenders.   We are…

Taiwan Chuan Lin, chairman of TTY Biopharm, one of Taiwan’s leading domestic biomedical players, highlights his ambition to lead the local success story onto the global stage. Chuan goes on to share the company’s transition strategy to leverage their innovative development platforms and manufacturing capabilities to be a partner of choice…

Korea One of the indisputable economic success stories of the last half-century, South Korea now stands as the world’s 11th largest economy, with a reputation for industrial excellence and innovation. As the Korean state shifts its focus towards healthcare and the life sciences and Korean firms begin to internationalize with greater…

Egypt Ashraf Osman, president and CEO of AUG Pharma, explains how his company has become one of Egypt’s Top 30 pharmaceutical companies in less than four years of manufacturing, gives an insight into the branding strategy of an industry newcomer, and outlines the company’s export strategy.   In 2018 alone we…

France CREAPHARM is a French company managing clinical supplies and providing CMO and distribution services for pharmaceuticals and cosmetics. Its CEO, Eric Placet, explains how he has reorganized the company to create synergies between the different business lines and breaks down the massive investments the company has made over the last…

Korea Kukjeon, originally a leading Korean pharmaceutical wholesaler, has in recent years expanded into API manufacturing. Its president, Jay Hong, explains his high-risk strategy to pursue new API business opportunities, and his plan to penetrate global markets from Japan to Europe.   My preferred strategy is to go down the path…

Spain On Becton Dickinson’s 40th anniversary in Spain, Lourdes López Jiménez, general manager of BD Spain & Portugal, introduces BD’s strong manufacturing footprint in the country and emphasizes the importance of the Spain to BD’s global operations. She also explains why she is so positive about the recent acquisition of Bard…